Hypertension — Pipeline

The premise

The mechanism we're betting on.

22 compounds across six BP-lowering mechanisms (RAAS, calcium-channel, vascular tone, volume, sympathetic, endothelial). 16-week mechanism-stratified protocol with ambulatory BP monitoring primary. The full mechanism map — including compound list, dose escalation, pre-specified biomarker thresholds, and the cross-walk modifiers used when re-fitting blends from related indications — is part of the gated methodology pack.Gated

RWE — real-world public landscape

What the rest of the world is doing.

Numbers below are surfaced by Atlas Bio's ClinicalTrials.gov and PubMed RWE pipelines, run against the Hypertension indication. Counts are industry-wide trials registered on ClinicalTrials.gov, not Atlas Bio studies. Methodology →

RWE refreshed 2026-05-12

Phase I (B1/B2)

200

trials

Phase II (B3)

200

trials

Phase III (B4)

200

trials

Phase IV (B5)

200

trials

Top public trials by enrollment

NCT00662480 · Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark · Central Jutland Regional Hospital · n=40,000 · PHASE4 · UNKNOWN

NCT00133692 · INVEST: INternational VErapamil SR Trandolapril STudy · University of Florida · n=22,000 · PHASE4 · COMPLETED

NCT00741585 · Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment · University of Vigo · n=21,983 · PHASE4 · COMPLETED

Recent published clinical evidence

Alcohol and hypertension. · PMID 1541032 · Clinical and experimental hypertension. Part A, Theory and p · 1992
Controlled clinical trials of drug treatment for hypertension. A review. · PMID 2490827 · Hypertension (Dallas, Tex. : 1979) · 1989
Community health worker-facilitated telehealth for moderate-severe hypertension care in Kenya and Uganda: A randomized controlled trial. · PMID 40472026 · PLoS medicine · 2025

Pre-registered predictions

Locked before readout.

Predictions for this study are SHA-256 locked before any readout. Pre-registration covers target engagement, primary endpoint, secondary endpoints, and the falsification criterion. The hash, prediction wording, and timestamp are available to verified clinicians and indication researchers on request.Gated

Methodology pillars used

Same stack, every indication.

M2 · Pre-Registration — SHA-256 locking before readout.
M1 · IBC Reasoning — 19-agent audit (11 core + 8 reasoning nodes).
M3 · Cross-Trial Validation — mechanism-anchored bridging across indications.
M4 · RWE Pipelines — ClinicalTrials.gov, PubMed, FDA, EDGAR feeds (the source of the numbers above).

Want the full Hypertension protocol?

The abstract above is open. Compound lists, dose escalations, SHA-256-locked prediction documents, agent-network reasoning chains, and trial design specifics are available to verified clinicians, indication researchers, and sponsors under MNDA. Contact management to begin the access request.

Contact management →